Core Scientific, Inc. Common Stock
Here’s whether Core Scientific, Inc. Common Stock (CORZ) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: strong 1-year return of +29.1%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-6.55% over 10 days); RSI 21 — oversold; 3-month momentum negative (-29.5%). Currently 41.5% off its 52-week high. Score: -5/7.
CORZ is trading below its 200-day MA ($19.75) — a key warning sign the longer-term trend is under pressure. An RSI of 21.1 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +29.1% compares to +20.5% for SPY (beat the market by 8.7%). The current 41.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.